ANONYMOUS TESTING OF NEWBORN-INFANTS FOR HIV ANTIBODIES AS A BASIS FOR ESTIMATING PREVALENCE OF HIV IN CHILDBEARING WOMEN - THE 1991-1994 STUDY IN SPAIN
Ca. Canosa et al., ANONYMOUS TESTING OF NEWBORN-INFANTS FOR HIV ANTIBODIES AS A BASIS FOR ESTIMATING PREVALENCE OF HIV IN CHILDBEARING WOMEN - THE 1991-1994 STUDY IN SPAIN, Acta paediatrica, 86, 1997, pp. 67-71
During 1991-1994, anonymous screening of newborn infants for maternal
antibody to human immunodeficiency virus (HIV) was carried out in thre
e regions of Spain: Valencia, Galicia and Sevilla. The newborn infants
whose heel-stick blood eluates were satisfactory for HIV antibody tes
ts were a consecutive series of 104 876, representing 99.3% of all new
born infants undergoing routine metabolic screening and estimated as c
omprising at least 98% of all births in the three regions. Enzyme immu
noassay (EIA) positives were confirmed by immunoblot, yielding 246 con
firmations: a rate of 2.3 per 1000. Seropositivity rates ranged from 1
.4 per 1000 in Galicia to 2.1 in Sevilla and 3.1 in Valencia, and rema
ined relatively stable in each region during the years of the study. W
ithin socioeconomically defined subgroups of birth hospitals in Valenc
ia and Galicia, all subgroups contained seropositives, even though the
re was a twofold to fivefold over-representation in the ''inner city''
public hospitals. To estimate the proportion of HIV-1-seropositive ne
wborn infants who were positive for HIV-1 DNA, polymerase chain reacti
on (PCR) assays were performed on 165 dried blood spots that had been
retained following positive immunoblot assays. Fifteen (9%) were PCR p
ositive, and when this proportion is adjusted for the age-specific sen
sitivity of the method, it translates into an estimated HIV-1 transmis
sion rate of 24% (range 18-36%). For 94 906 of the 104 876 newborn inf
ants screened, the EIA used could detect antibodies that react with ep
itopes of HIV-1 and HIV-2. Then were 30 newborn infants whose blood el
uate was positive by this combined HIV-1/HIV-2 antibody screen and who
se secondary screening with monovalent HIV-2 and HIV-1 EIA indicated t
hat the HIV-2 reactivity was above the cut-off whereas the HIV-1 was n
ot. Ranking these 30 results according to absolute HIV-2 reactivity an
d relative reactivity with respect to HIV-1 indicated that four infant
s were probable true HIV-2 seropositives and a total of 12 were possib
le HIV-2 seropositives, a prevalence of the order of 1:10000 to 1:2000
0 newborn infants. These anonymous population-based serological studie
s provide ''leading-indicator'' data to complement traditional AIDS su
rveillance for epidemiological and planning purposes.